rood blauwe elepsis logo Belegger.nl
Uitgebreid zoeken

Radio Pharming !

45.629 Posts
Pagina: «« 1 ... 2015 2016 2017 2018 2019 ... 2282 »» | Laatste | Omlaag ↓
  2. forum rang 7 Jager63 15 februari 2023 08:23

    • Jager63

      Lid sinds: 09 okt 2020

      Laatste bezoek: 14 apr 2025

    • Aanbevelingen

      Ontvangen: 4462

      Gegeven: 1414

    •    Aantal posts: 15.437

    quote:

    vdx777 schreef op 15 februari 2023 08:14:

    [...]

    link werk wel hoor
    leuk jager :)
    Was een andere link (die ik al weggehaald heb).
  18. forum rang 7 Jager63 16 februari 2023 10:27

    • Jager63

      Lid sinds: 09 okt 2020

      Laatste bezoek: 14 apr 2025

    • Aanbevelingen

      Ontvangen: 4462

      Gegeven: 1414

    •    Aantal posts: 15.437

    Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe
    EMA Marketing Authorisation Application for leniolisib changed to standard review timetable
    Leiden, The Netherlands, February 16, 2023
    Pharming Group N.V. ("Pharming" or "the Company") (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces that the European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP) has decided to shift its assessment of the Marketing Authorisation Application (MAA) for leniolisib to a standard review timetable. Leniolisib is an oral selective phosphoinositide 3-kinase delta (PI3Kd) inhibitor under regulatory review as a treatment for activated phosphoinositide 3-kinase delta syndrome (APDS), a rare primary immunodeficiency, in adolescents and adults 12 years of age and older.

    Pharming has received the list of questions from EMA which included a request to submit updated data from the ongoing long-term extension study collected after the interim analysis included in the original MAA. Based on the timetable for our responses, Pharming expects that CHMP will issue its opinion on the leniolisib MAA in 2H 2023.

    Sijmen de Vries, CEO of Pharming commented:
    "We are continuing to work with EMA through the MAA review process and remain dedicated to seeking regulatory approval of leniolisib within the European Economic Area. In the US, the FDA's priority review of the leniolisib NDA remains on track, with a PDUFA goal date of March 29, 2023. We remain focused on achieving regulatory approvals and bringing leniolisib to patients living with APDS worldwide."
45.629 Posts
Pagina: «« 1 ... 2015 2016 2017 2018 2019 ... 2282 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.163
AB InBev 2 5.545
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.507
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.931
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 193
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.892
Aedifica 3 927
Aegon 3.258 323.213
AFC Ajax 538 7.093
Affimed NV 2 6.306
ageas 5.844 109.911
Agfa-Gevaert 14 2.075
Ahold 3.538 74.363
Air France - KLM 1.025 35.332
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.073
Alfen 16 25.505
Allfunds Group 4 1.525
Almunda Professionals (vh Novisource) 651 4.252
Alpha Pro Tech 1 17
Alphabet Inc. 1 427
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 244.271
AMG 972 134.761
AMS 3 73
Amsterdam Commodities 305 6.757
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 501
Antonov 22.632 153.605
Aperam 92 15.108
Apollo Alternative Assets 1 17
Apple 5 387
Arcadis 252 8.808
Arcelor Mittal 2.035 321.101
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.381
Aroundtown SA 1 221
Arrowhead Research 5 9.759
Ascencio 1 30
ASIT biotech 2 697
ASMI 4.108 39.700
ASML 1.767 112.361
ASR Nederland 21 4.522
ATAI Life Sciences 1 7
Atenor Group 1 523
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 14.353
Axsome Therapeutics 1 177
Azelis Group 1 69
Azerion 7 3.463